Clinical Trial Update: A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing immunotherapy combined with neoadjuvant therapy versus neoadjuvant therapy alone for stage II-III breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Shengjing Hospital | Conditions: Stage II-III Breast Cancer | Phase 2 | Status: UNKNOWN